|Articles|January 1, 2008
HPV, shingles vaccines forge ahead
Since its pivotal study, Gardasil has proven safe and effective in a five-year follow-up study, and it can also help women already infected with HPV, says an expert. Meanwhile, he adds, researchers have begun studying the efficacy of the Zostavax shingles virus in patients under 60.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5















